Literature DB >> 18638541

Neuroendocrine modulation of cancer progression.

Guillermo N Armaiz-Pena1, Susan K Lutgendorf, Steve W Cole, Anil K Sood.   

Abstract

Clinical and animal studies now support the notion that psychological factors such as stress, chronic depression, and lack of social support might promote tumor growth and progression. Recently, cellular and molecular studies have started to identify biological processes that could mediate such effects. This review provides a mechanistic understanding of the relationship between biological and behavioral influences in cancer and points to more comprehensive behavioral and pharmacological approaches for better patient outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18638541      PMCID: PMC2630522          DOI: 10.1016/j.bbi.2008.06.007

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  42 in total

Review 1.  Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland.

Authors:  M J Bissell
Journal:  Biochem Soc Trans       Date:  2007-02       Impact factor: 5.407

2.  Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress.

Authors:  Anthony S L Chan; Linda W C Ng; Lydia S W Poon; Winnie W Y Chan; Yung H Wong
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

Review 3.  Epac proteins: multi-purpose cAMP targets.

Authors:  Johannes L Bos
Journal:  Trends Biochem Sci       Date:  2006-11-02       Impact factor: 13.807

4.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Authors:  Premal H Thaker; Liz Y Han; Aparna A Kamat; Jesusa M Arevalo; Rie Takahashi; Chunhua Lu; Nicholas B Jennings; Guillermo Armaiz-Pena; James A Bankson; Murali Ravoori; William M Merritt; Yvonne G Lin; Lingegowda S Mangala; Tae Jin Kim; Robert L Coleman; Charles N Landen; Yang Li; Edward Felix; Angela M Sanguino; Robert A Newman; Mary Lloyd; David M Gershenson; Vikas Kundra; Gabriel Lopez-Berestein; Susan K Lutgendorf; Steven W Cole; Anil K Sood
Journal:  Nat Med       Date:  2006-07-23       Impact factor: 53.440

5.  Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.

Authors:  Monique B Nilsson; Guillermo Armaiz-Pena; Rie Takahashi; Yvonne G Lin; Jose Trevino; Yang Li; Nicholas Jennings; Jesusa Arevalo; Susan K Lutgendorf; Gary E Gallick; Angela M Sanguino; Gabriel Lopez-Berestein; Steven W Cole; Anil K Sood
Journal:  J Biol Chem       Date:  2007-08-23       Impact factor: 5.157

6.  Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.

Authors:  Eric V Yang; Anil K Sood; Min Chen; Yang Li; Tim D Eubank; Clay B Marsh; Scott Jewell; Nicholas A Flavahan; Carl Morrison; Peir-En Yeh; Stanley Lemeshow; Ronald Glaser
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine.

Authors:  Eric V Yang; Elise L Donovan; Don M Benson; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2007-11-05       Impact factor: 7.217

8.  Personality factors and breast cancer risk: a 13-year follow-up.

Authors:  Eveline M A Bleiker; Jan H C L Hendriks; Johannes D M Otten; André L M Verbeek; Henk M van der Ploeg
Journal:  J Natl Cancer Inst       Date:  2008-01-29       Impact factor: 13.506

Review 9.  The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.

Authors:  Michael H Antoni; Susan K Lutgendorf; Steven W Cole; Firdaus S Dhabhar; Sandra E Sephton; Paige Green McDonald; Michael Stefanek; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2006-03       Impact factor: 60.716

10.  Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.

Authors:  Charles N Landen; Yvonne G Lin; Guillermo N Armaiz Pena; Pamela D Das; Jesusa M Arevalo; Aparna A Kamat; Liz Y Han; Nicholas B Jennings; Whitney A Spannuth; Premal H Thaker; Susan K Lutgendorf; Cherylyn A Savary; Angela M Sanguino; Gabriel Lopez-Berestein; Steve W Cole; Anil K Sood
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

View more
  52 in total

Review 1.  Neuroendocrine influences on cancer progression.

Authors:  Guillermo N Armaiz-Pena; Steve W Cole; Susan K Lutgendorf; Anil K Sood
Journal:  Brain Behav Immun       Date:  2012-06-21       Impact factor: 7.217

2.  Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.

Authors:  Donald M Lamkin; Erica K Sloan; Ami J Patel; Beverley S Chiang; Matthew A Pimentel; Jeffrey C Y Ma; Jesusa M Arevalo; Kouki Morizono; Steve W Cole
Journal:  Brain Behav Immun       Date:  2012-01-25       Impact factor: 7.217

3.  Caregiving burden, stress, and health effects among family caregivers of adult cancer patients.

Authors:  Margaret Bevans; Esther M Sternberg
Journal:  JAMA       Date:  2012-01-25       Impact factor: 56.272

4.  Beta-adrenergic blocking drugs in breast cancer: a perspective review.

Authors:  Thomas I Barron; Linda Sharp; Kala Visvanathan
Journal:  Ther Adv Med Oncol       Date:  2012-05       Impact factor: 8.168

5.  Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.

Authors:  Maxwell N Skor; Erin L Wonder; Masha Kocherginsky; Anju Goyal; Ben A Hall; Yi Cai; Suzanne D Conzen
Journal:  Clin Cancer Res       Date:  2013-09-09       Impact factor: 12.531

6.  Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer.

Authors:  Carolyn Y Fang; Brian L Egleston; John A Ridge; Miriam N Lango; Dana H Bovbjerg; Jamie L Studts; Barbara A Burtness; Margret B Einarson; Andres J P Klein-Szanto
Journal:  Head Neck       Date:  2013-10-26       Impact factor: 3.147

7.  Hypothalamic gene transfer of BDNF inhibits breast cancer progression and metastasis in middle age obese mice.

Authors:  Xianglan Liu; Travis McMurphy; Run Xiao; Andrew Slater; Wei Huang; Lei Cao
Journal:  Mol Ther       Date:  2014-03-18       Impact factor: 11.454

8.  Impact of cardiovascular comorbidity on ovarian cancer mortality.

Authors:  Eileen H Shinn; Daniel J Lenihan; Diana L Urbauer; Karen M Basen-Engquist; Alan Valentine; Laura Palmero; Myrshia L Woods; Pooja Patel; Alpa M Nick; Mian M K Shahzad; Rebecca L Stone; Antoinette Golden; Emma Atkinson; Susan K Lutgendorf; Anil K Sood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

9.  Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer.

Authors:  Donghao Lu; Jennifer A Sinnott; Lorelei A Mucci; Katja Fall; Unnur Valdimarsdóttir; Fang Fang; Travis Gerke; Svitlana Tyekucheva; Michelangelo Fiorentino; Mats Lambe; Howard D Sesso; Christopher J Sweeney; Kathryn M Wilson; Edward L Giovannucci; Massimo Loda
Journal:  Clin Cancer Res       Date:  2015-10-21       Impact factor: 12.531

10.  VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors.

Authors:  Bruna Maria Rodrigues Vilardi; Diego Mauricio Bravo-Calderón; Daniel Galera Bernabé; Sandra Helena Penha Oliveira; Denise Tostes Oliveira
Journal:  Tumour Biol       Date:  2012-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.